BSG and pancreatic neoplasm: Using such an approach, a mAb targeting CD147, a transmembrane protein overexpressed in tumours including pancreatic cancer, was shown to induce ADCC and to inhibit the growth of PANC-1 pancreatic cancer cells [74,75].